Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-03

Clinical Trial Update: Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS) [NA]

View source ↗

Summary

A completed clinical trial evaluated the efficacy of albumin dialysis using the MARS system to treat hepatic encephalopathy in patients with liver failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MARS (Molecular Adsorbent Recirculating System)

Snippet

Sponsor: Vantive Health LLC | Conditions: Hepatic Encephalopathy, Liver Failure | NA | Status: COMPLETED